More Press Releases in:

Medicine & Healthcare, For Dummies

Hoboken, NJ

Diabetes For Dummies® Updated to Provide New Developments in Treatment and Prevention

Diabetes is now considered pandemic throughout the world. The International Diabetes Federation reports that 366 million people had diabetes in 2011 and that 552 million will have the disease by 2030 – that’s one in every ten people on Earth. Fortunately, since the publication of the third edition of Diabetes For Dummies® in 2008, there has been an enormous amount of work done in the field. There are new ways to diagnose and treat both short- and long-term complications and new information on the psychology of diabetes and its treatment.

Diabetes For Dummies author Dr. Alan L. Rubin says, “So much has changed in the four years since the third edition was written that a fourth edition was clearly necessary. I need to tell you about new medicines, new glucose meters, and new ideas about diet and exercise. I also need to share new information about diabetes in children and the occupational and insurance problems of people with diabetes.”

Diabetes For Dummies, 4th Edition (Wiley, 978-1-118-29447-5, September 2012) also exposes false promises from drug companies and supplement makers and spotlights proposals for diabetes care that have not been carefully evaluated.

“In previous editions, I have enthusiastically spoken about the great efforts of pharmaceutical companies to provide you with the best drugs to lower your glucose, reduce your blood pressure, and lower your cholesterol. In this edition, I have the sad responsibility to warn you about these same pharmaceutical companies,” says Dr. Rubin.

The always popular “Part of Tens” runs through ten ways to prevent or reverse the effects of diabetes and ten myths about diabetes that you can forget (“pregnancy is not an option for women with diabetes,” “you have to be overweight to get diabetes,” among others).

The Cheat Sheet on Dummies.com includes screening guidelines for diabetes, ten rules for diabetes control, standards for continuing care, and information on oral drugs for Type 2 diabetes.